01672.HK
Ascletis Pharma Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 4.90
−6.04%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.35x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.78x
- Price / sales
- 4279.28x
- Price / cash flow
- -8.10x
Enterprise value
- Enterprise value
- HKD 2.1B
- EV / sales
- 1889.40x
- EV / EBITDA
- -2.75x
- EV / EBIT
- -2.68x
- Market cap
- HKD 4.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026